Helene Mathieu-Daude
Overview
Explore the profile of Helene Mathieu-Daude including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Champeaux Depond C, Zouaoui S, Darlix A, Rigau V, Mathieu-Daude H, Bauchet F, et al.
Acta Neurochir (Wien)
. 2024 Aug;
166(1):320.
PMID: 39093339
Purpose: Meningeal solitary fibrous tumour (SFT) and haemangiopericytoma (HPC) are uncommon tumours that have been merged into a single entity in the last 2021 WHO Classification of Tumors of the...
2.
Champeaux Depond C, Zouaoui S, Darlix A, Rigau V, Mathieu-Daude H, Bauchet F, et al.
Acta Neurochir (Wien)
. 2024 May;
166(1):214.
PMID: 38740641
Background And Objectives: Meningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and...
3.
Ng S, Zouaoui S, Bessaoud F, Rigau V, Roux A, Darlix A, et al.
Neuro Oncol
. 2019 Dec;
22(6):851-863.
PMID: 31796950
Background: Primary central nervous system tumors (PCNST) among adolescents and young adults (AYA, 15-39 y) have rarely been reported. We present a nationwide report of PCNST histologically confirmed in the...
4.
Fabbro-Peray P, Zouaoui S, Darlix A, Fabbro M, Pallud J, Rigau V, et al.
J Neurooncol
. 2018 Dec;
142(1):91-101.
PMID: 30523606
Background: Glioblastoma is the most frequent primary malignant brain tumor. In daily practice and at whole country level, oncological care management for glioblastoma patients is not completely known. Objectives: To...
5.
Senesse P, Isambert A, Janiszewski C, Fiore S, Flori N, Poujol S, et al.
J Pain Symptom Manage
. 2017 Aug;
54(3):387-393.e3.
PMID: 28778558
Context: Cancer-associated cachexia is correlated with survival, side-effects, and alteration of the patients' well-being. Objectives: We implemented an institution-wide multidisciplinary supportive care team, a Cancer Nutrition Program (CNP), to screen...
6.
Darlix A, Zouaoui S, Rigau V, Bessaoud F, Figarella-Branger D, Mathieu-Daude H, et al.
J Neurooncol
. 2016 Dec;
131(3):547.
PMID: 27957669
No abstract available.
7.
Darlix A, Zouaoui S, Rigau V, Bessaoud F, Figarella-Branger D, Mathieu-Daude H, et al.
J Neurooncol
. 2016 Nov;
131(3):525-546.
PMID: 27853959
Primary central nervous system tumors (PCNST) are rare tumors responsible for high mortality and morbidity. Their epidemiology is poorly known, and clinical data are scarcely analyzed at a national level....
8.
Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France
Darlix A, Zouaoui S, Virion J, Rigau V, Mathieu-Daude H, Blonski M, et al.
J Neurooncol
. 2014 Aug;
120(3):547-55.
PMID: 25151505
Diffuse WHO grade II and III gliomas (DGII/IIIG) are rare tumors, with few specific epidemiological studies. We aimed at describing the geographical distribution of a homogeneous series of histologically confirmed...
9.
Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daude H, Rigau V, Fabbro M, et al.
Neurosurg Rev
. 2014 Feb;
37(3):415-23.
PMID: 24526367
The incidence of glioblastoma (GBM) has increased in patients aged 70 years or older, and will continue to grow. Elderly GBM patients have been excluded from most clinical trials; furthermore,...
10.
Scott J, Bauchet L, Fraum T, Nayak L, Cooper A, Chao S, et al.
Cancer
. 2012 Apr;
118(22):5595-600.
PMID: 22517216
Background: The most-used prognostic scheme for malignant gliomas included only patients aged 18 to 70 years. The purpose of this study was to develop a prognostic model for patients ≥70...